Is Bavarian Nordic A/S (BVNKF) a Buy, Sell, or Hold?
OTC : BVNKF
Bavarian Nordic A/S
$27.69 USD
$0 (0.0%)
- Volume
- 100
- Average Volume
- 111
- Market Capitalization
- $2.14B
- P/E Ratio
- 11.95
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $37.60
- Year Low
- $27.69
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.47
Company Overview
OTC
Paul Chaplin
Biotechnology
Healthcare
BVNKF
1744
DK
USD
Liquidity Metrics
0.01
6.47
3.58
0.75
0.00
Sales & Valuation
$6.16B
2.23
1.06
9.59
17.83
Profitability
$17.61
$1.37B
19.83%
26.95%
9.25%
8.32%
P/E Metrics
11.95
-0.93
-0.93
Analyst Price Target & Rating
3/5
0 Analysts
%
Financial Health Scores
8.31
7/9
$5.05B
$14.12B
$1.42B
$1.52B
Key Metrics (TTM)
$12.64B
2.14
5.63
6.47
9.25%
8.35%
8.72%
10.42%
$237.27
326 days
Company Executives
| Name | Title |
|---|---|
| Rolf Sass Sørensen | Vice President of Investor Relations |
| Russell Thirsk | Executive Vice President & Chief Operating Officer |
| Nicole Seroff | Vice President Corporate Communications |
| Paul John Chaplin | Chief Executive Officer & President |
| Henrik Juuel | Chief Financial Officer & Executive Vice President |
| Jean-Christophe May | Executive Vice President & Chief Commercial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Bavarian Nordic A/S (OTC:BVNKF) Stock
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark. ...
Bavarian Nordic A/S (BVNRY) Q1 2026 Earnings Call Transcript
2026-05-13 10:50:46
Bavarian Nordic A/S (BVNRY) Q1 2026 Earnings Call Transcript
Denmark's Bavarian Nordic raises 2026 forecast
2026-05-11 12:53:06
Denmark's Bavarian Nordic on Monday raised its revenue guidance for 2026 to 5.5 billion - 5.7 billion Danish crowns ($866.93 million-$898.46 million).
Frequently Asked Questions
-
What is the current Bavarian Nordic A/S (BVNKF) stock price?
-
Bavarian Nordic A/S(OTC:BVNKF) stock price is $27.69 in the last trading session. During the trading session, BVNKF stock reached the peak price of $37.6 while $27.69 was the lowest point it dropped to. The percentage change in BVNKF stock occurred in the recent session was 0.0% while the dollar amount for the price change in BVNKF stock was $0.
-
BVNKF's industry and sector of operation?
-
The OTC listed BVNKF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of BVNKF?
-
Rolf Sass Sørensen | Vice President of Investor Relations
Russell Thirsk | Executive Vice President & Chief Operating Officer
Nicole Seroff | Vice President Corporate Communications
Paul John Chaplin | Chief Executive Officer & President
Henrik Juuel | Chief Financial Officer & Executive Vice President -
How many employees does BVNKF have?
-
Number of BVNKF employees currently stands at 1744. BVNKF operates from Philip Heymans Alle 3, Hellerup, CR 2900, DK.
-
Link for BVNKF official website?
-
Official Website of BVNKF is: https://www.bavarian-nordic.com
-
How do I contact BVNKF?
-
BVNKF could be contacted at phone #45 33 26 83 83 and can also be accessed through its website. BVNKF operates from Philip Heymans Alle 3, Hellerup, CR 2900, DK.
-
How many shares of BVNKF are traded daily?
-
The average number of BVNKF shares traded daily for last 3 months was 111.
-
What is the market cap of BVNKF currently?
-
The market value of BVNKF currently stands at $2.14B with its latest stock price at $27.69